Global Outcome in Patients with Left Ventricular Assist Devices

Abstract LVADs improve survival and quality of life (QOL) for most, but not all, patients with advanced heart failure. We described a broader definition of poor outcomes post-LVAD, using a novel composite of death, QOL, and other major adverse events. We evaluated the frequency of poor global outcom...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2017-04, Vol.119 (7), p.1069-1073
Hauptverfasser:	Fendler, Timothy J., MD, MS, Nassif, Michael E., MD, Kennedy, Kevin F., MS, Joseph, Susan M., MD, Silvestry, Scott C., MD, Ewald, Gregory A., MD, LaRue, Shane J., MD, MPHS, Vader, Justin M., MD, MPHS, Spertus, John A., MD, MPH, Arnold, Suzanne V., MD, MHA
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood clots Cardiomyopathy Cardiovascular Cardiovascular disease Female Heart failure Heart Failure - mortality Heart Failure - physiopathology Heart Failure - therapy Heart-Assist Devices Hospitals Humans Infections Male Middle Aged Missouri - epidemiology Mortality Patients Quality of Life Questionnaires Registries Retrospective Studies Risk Assessment Stroke Studies Surveys and Questionnaires Thrombosis Transplants & implants Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract LVADs improve survival and quality of life (QOL) for most, but not all, patients with advanced heart failure. We described a broader definition of poor outcomes post-LVAD, using a novel composite of death, QOL, and other major adverse events. We evaluated the frequency of poor global outcome at 1 year post-LVAD among 164 patients (86% INTERMACS Profile 1-2; shock or declining despite inotropes) at a high-volume center. Poor global outcome (comprising death, poor QOL [KCCQ
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2016.12.014